4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-029148
Interim Chief Medical Officer sold 130,056 shares at $1.06 ($137,859)
- Interim Chief Medical Officer acquired 269,893 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stewart Murray Interim Chief Medical Officer | 2023-08-09 | Grant or award | +269,893 | 276,560 | D | ||
| Stewart Murray Interim Chief Medical Officer | 2023-08-10 | Sale | −130,056 | $1.06 | $137,859 | 146,504 | D |
| Open-market sales · 130,056 sh · avg $1.06 · $137,859 | |||||||
Loading xslF345X05/wk-form4_1691796370.xml…